TREM2 Antibody (237920) [Phycoerythrin]

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

TREM-2 (Triggering Receptor Expressed on Myeloid cells-2) is a 35 kDa molecular weight type I transmembrane member of the TREM family and Ig superfamily . Mature human TREM-2 consists of a 156 amino acid (aa) extracellular domain (ECD) with one V-type Ig-like domain, a 21 aa transmembrane (TM) domain, and a 35 aa cytoplasmic tail. Within the ECD, human TREM-2 shares 73% and 74% aa sequence identity with mouse and rat TREM-2, respectively. Two closely related transcripts were reported in mouse and designated TREM-2a and TREM-2b. Soluble forms of the TREM-2 ECD are generated by alternative splicing or proteolytic cleavage, and the cytoplasmic domain can be liberated by gamma-Secretase mediated intramembrane cleavage. It is a pattern recognition receptor that binds anionic ligands. A positively charged lysine within the transmembrane segment allows association with the signal adapter protein, DAP12 to deliver an activating signal that plays a role in both innate and adaptive immune responses, including inhibition of macrophage activation. TREM-2 is expressed on macrophages, immature myeloid dendritic cells, osteoclasts, microglia, and adipocytes. It promotes the differentiation and function of osteoclasts, the production of inflammatory cytokines by adipocytes, insulin resistance, and the phagocytic clearance of bacteria. In the CNS, TREM-2 binds to ApoE, ApoA1, and ApoB and mediates the clearance of apoptotic neurons, amyloid plaques, and cell debris following demyelination. TREM-2 also interacts with and modifies signaling through Plexin A1 on dendritic cells and osteoclasts. Mutations in TREM-2 or DAP12 are associated with the development of Alzheimer's disease and Nasu-Hakola disease (NHD/PLOSL) which is characterized by presenile dementia and bone cysts. Soluble TREM-2 is elevated in cerebrospinal fluid of patients with active multiple sclerosis (MS), and TREM-2 blockade exacerbates disease symptoms in the experimental EAE model of MS.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 2 confirmed species: Mouse, Transgenic Mouse.

We have publications tested in 1 application: Flow Cytometry.

Showing Publications 1 - 9 of 9.

Publications using FAB17291P	Applications	Species
Zhang, J;Chang, J;Chen, V;Beg, MA;Huang, W;Vick, L;Wang, Y;Zhang, H;Yttre, E;Gupta, A;Castleberry, M;Zhang, Z;Dai, W;Song, S;Zhu, J;Yang, M;Brown, AK;Xu, Z;Ma, YQ;Smith, BC;Zielonka, J;Traylor, JG;Dhaou, CB;Orr, AW;Cui, W;Zheng, Z;Chen, Y; Oxidized LDL regulates efferocytosis through the CD36-PKM2-mtROS pathway bioRxiv : the preprint server for biology 2024-07-15 [PMID: 39071358] (Flow Cytometry, Mouse, Transgenic Mouse)	Flow Cytometry	Mouse, Transgenic Mouse
Fulton, SL;Bendl, J;Gameiro-Ros, I;Fullard, JF;Al-Kachak, A;Lepack, AE;Stewart, AF;Singh, S;Poller, WC;Bastle, RM;Hauberg, ME;Fakira, AK;Chen, M;Cuttoli, RD;Cathomas, F;Ramakrishnan, A;Gleason, K;Shen, L;Tamminga, CA;Milosevic, A;Russo, SJ;Swirski, F;Blitzer, RD;Slesinger, PA;Roussos, P;Maze, I; ZBTB7A regulates MDD-specific chromatin signatures and astrocyte-mediated stress vulnerability in orbitofrontal cortex bioRxiv : the preprint server for biology 2023-05-04 [PMID: 37205394] (Flow Cytometry, Mouse)	Flow Cytometry	Mouse
Hao-Yuan Wang, Fu-Chen Yang, Ching-Fen Yang, Yao-Chung Liu, Po-Shen Ko, Chien-Jung Li et al. Surface TREM2 on circulating M-MDSCs as a novel prognostic factor for adults with treatment-naïve diffuse large B-cell lymphoma Experimental Hematology & Oncology 4/7/2023 [PMID: 37029450]
S Li, J Yu, A Huber, I Kryczek, Z Wang, L Jiang, X Li, W Du, G Li, S Wei, L Vatan, W Szeliga, AM Chinnaiyan, MD Green, M Cieslik, W Zou Metabolism drives macrophage heterogeneity in the tumor microenvironment Cell Reports, 2022-04-05;39(1):110609. 2022-04-05 [PMID: 35385733] (Flow Cytometry, Mouse)	Flow Cytometry	Mouse
CS McAlpine, J Park, A Griciuc, E Kim, SH Choi, Y Iwamoto, MG Kiss, KA Christie, C Vinegoni, WC Poller, JE Mindur, CT Chan, S He, H Janssen, LP Wong, J Downey, S Singh, A Anzai, F Kahles, M Jorfi, PF Feruglio, RI Sadreyev, R Weissleder, BP Kleinstive, M Nahrendorf, RE Tanzi, FK Swirski Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease Nature, 2021-07-14;595(7869):701-706. 2021-07-14 [PMID: 34262178] (Flow Cytometry, Mouse)	Flow Cytometry	Mouse
M Hu, Y Lin, X Men, S Wang, X Sun, Q Zhu, D Lu, S Liu, B Zhang, W Cai, Z Lu High-salt diet downregulates TREM2 expression and blunts efferocytosis of macrophages after acute ischemic stroke Journal of Neuroinflammation, 2021-04-12;18(1):90. 2021-04-12 [PMID: 33845849] (Flow Cytometry, Mouse)	Flow Cytometry	Mouse
Y Vagima, D Gur, N Erez, H Achdout, M Aftalion, Y Levy, A Zauberman, A Tidhar, H Gutman, S Lazar, T Israely, N Paran, S Melamed, T Brosh-Niss, T Chitlaru, I Sagi, E Mamroud Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments Sci Rep, 2020-11-05;10(1):19116. 2020-11-05 [PMID: 33154422] (Flow Cytometry, Mouse)	Flow Cytometry	Mouse
Catherine Béchade, Ivana D'Andrea, Fanny Etienne, Franck Verdonk, Imane Moutkine, Sophie M. Banas et al. The serotonin 2B receptor is required in neonatal microglia to limit neuroinflammation and sickness behavior in adulthood Glia 3/1/2021 [PMID: 33095507]
Clark GJ et al. New insights into the phenotype of human dendritic cell populations. Clin Transl Immunology 1/1/2016 [PMID: 26900474]

Array FAB17291P

• TREM2 Antibodies
• TREM2 Antibody Pair
• TREM2 ELISA Kits
• TREM2 Lysate
• TREM2 Protein
• TREM2 ELISA
• TREM2 Proteins and Enzymes